Connecticut Innovations — 2016 Investments
5 investments dated 2016 · listed companies and verified rows first · show all
Tantalus provides a Grid Modernization Platform that enables utilities to manage electricity distribution infrastructure through data interoperability across devices and systems, including legacy equipment and distributed energy resources.
Data & InfrastructureEnergyIoTBurnaby
John McEwen(Director)Dermot O'Leary(Executive Officer)Francis Harvey(Director)Peter Londa(Executive Officer, Director)
BoardAllen Beasley(Director)
Aeromics is a clinical-stage biopharmaceutical company developing AER-271, an aquaporin-4 inhibitor to prevent cerebral edema (brain swelling) in severe acute ischemic stroke patients.
BiotechMedical DevicesNew Haven, US
Dr. Pelletier(Founder)Dr. Boron(Founder)Frederick Jones(Director)Paul McGuirk(Executive Officer)Walter Boron(Executive Officer, Director)George Farr(Executive Officer)
BiologicsMD develops recombinant fusion proteins targeting parathyroid hormone receptors for hair loss, bone disorders, and oncology treatments.
BiotechDeep TechMedical DevicesFayetteville, US
Ramsay Ball(Director)Robyn Goforth(Executive Officer)Calvin Goforth(Director, Promoter)Rob Gensure(Executive Officer)J. David Owens(Executive Officer, Director)Lynn Kirkpatrick(Director)
BioWave develops a wearable neurostimulation device that delivers high-frequency electrical stimulation directly to nerves to block pain signals, marketed as a treatment for chronic pain conditions without requiring continuous use.
HealthtechMedical DevicesNorwalk, US
Robert Adler(President)Bradford Siff(CEO and Secretary)Lance Lundberg(Director)L. Charles (Duke) Meythaler(Director)Bruce Lev(Director)David Kratovil(Chief Operating Officer)
Mitotherapeutix develops siRNA-based drugs targeting mitochondrial metabolic regulation through RNA silencing.
AI & Machine LearningBiotechMedical DevicesWoodbridge, US
Robert Hemley(Executive Officer, Director)Robert Hennessey(Executive Officer, Director)John V. Talley(Executive Officer, Director)
BoardFenel Eloi(Director)Daniel Wagner(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.